A large number of drugstores are included in the volume purchase, and the "new era of parity" is coming

[pharmaceutical network industry trends] recently, Yixintang said that it will directly participate in the volume purchase business in the main business areas, and will mainly implement the same price policy for the volume purchase varieties sold by the company It is understood that since December 2019, another leading pharmaceutical retail enterprise has announced to follow up the purchase of 4 + 7 products with the same price as the same product in the hospital, following the Yusuo civilians, Yikang medicine, ordinary people and dashanlin To this, the personage inside course of study expresses one after another, the collection time of retail drugstore arrived! In fact, in the past two years, under the circumstances of policy and opponents' back and forth attack, it is a must and strategic choice for retail pharmacies to follow up the centralized purchase and price reduction   It is understood that in the opinions on the implementation of the pilot drug centralized purchase and use by national organizations to expand the regional scope jointly issued by 9 departments such as the medical insurance bureau, it was made clear that if the designated retail pharmacies of medical insurance participate in the purchase, they can be allowed to increase the price appropriately on the basis of the selected price, the part exceeding the payment standard shall be paid by the patients themselves, and the part below the payment standard shall be paid by the medical insurance according to the regulations Reimbursement In order to respond to the national policy, Shandong, Zhejiang, Shanghai, Guangdong and other provinces have issued a notice that they will collect Medicare drugs from pharmacies and incorporate them into the procurement channels of the medical insurance system For example, in the implementation plan of implementing the pilot expansion of centralized drug purchase and use in Shandong Province issued in October 2019, Shandong Province has defined the scope of institutions with volume procurement: all public medical institutions in the province participate in the pilot expansion, and private medical institutions and retail pharmacies at the medical insurance agreement point actively participate A few days ago, the first round of launching ceremony of centralized purchase was also held in Guangdong pharmaceutical retail industry alliance Therefore, with the strong support of the policy and the response from all over the country, the chain drugstores have followed up the collection, which can also be said to be a trend For example, Yifeng pharmacy announced on December 18 last year that consumers who purchase drugs of the same factory and specifications that are lower than the retail price of other pharmacies within 2 kilometers will return 3 times the difference between small sales units of drugs On December 20, ordinary people's pharmacy promised to "refund three times the difference" in the official micro pharmacy, and 5000 + stores and hospitals across the country "have the same price for the same medicine" On January 10, dashanlin made a statement that since January 1, 2020, more than 4000 stores under dashanlin have responded to the national centralized purchase policy and reduced prices for corresponding varieties At present, in addition to the listed chain drugstores, the leading chain enterprises such as Shuyu civilian drugstore and Yikang medicine have also followed up the price reduction In this regard, some insiders said that in the future, with more and more drugstores participating in the centralized purchase, there is no doubt that higher requirements have been put forward for drugstores in terms of business scale, medical insurance qualification and other aspects, and there will be the result of survival of the fittest, so drugstores need to be prepared On the whole, the shock wave of drug collection has hit retail drugstores irresistibly, and more provinces will participate in the start of drug collection this year In the short term, retail drugstores will leave the era of high gross profit and think about the way of innovative operation under the "strategic loss" In the long term, the concentration of chain drugstores will gradually increase, which will become an inevitable trend.